Clal Biotechnology Industries Ltd (CBI) — Cash Flow Quality Index
Clal Biotechnology Industries Ltd (CBI) has a Cash Flow Quality Index of -1.51x as of June 2023. Operating cash flow of ILA-1.82 Million is below net income of ILA1.21 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore debt repayment capacity of Clal Biotechnology Industries Ltd to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Clal Biotechnology Industries Ltd Cash Flow Quality Index (2009–2020)
Historical Cash Flow Quality Index for Clal Biotechnology Industries Ltd across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Clal Biotechnology Industries Ltd (CBI) cash flow conversion.
Annual Cash Flow Quality Index for Clal Biotechnology Industries Ltd (2009–2020)
Year-by-year earnings quality comparison for Clal Biotechnology Industries Ltd.
| Year | Quality Index | Operating CF (ILA) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | -0.30x | ILA-33.23 Million | ILA109.03 Million | ▲ +13.9% |
| 2010 | -0.35x | ILA-111.93 Million | ILA316.19 Million | ▲ +79.4% |
| 2009 | -1.72x | ILA-86.86 Million | ILA50.55 Million | — |